Virus-based advanced therapy medicinal products (ATMPs)
Breaking new ground with virus-based ATMPs
Virus-based ATMPs offer new opportunities in addressing unmet medical needs and improving treatments for many diseases and injuries.
We at Coriolis can support these efforts by performing formulation development for virus-based ATMPs up to the Biosafety level (BSL) 2 for liquid as well as lyophilized products. Already at an early stage, Coriolis can assess the developability of virus-based ATMPs by utilizing the large in-house analytical capabilities.
Contact our experts today and find out how we can support your product development.